111 related articles for article (PubMed ID: 18677381)
21. Mild hyperoxia limits hTR levels, telomerase activity, and telomere length maintenance in hTERT-transduced bone marrow endothelial cells.
Napier CE; Veas LA; Kan CY; Taylor LM; Yuan J; Wen VW; James A; O'Brien TA; Lock RB; MacKenzie KL
Biochim Biophys Acta; 2010 Oct; 1803(10):1142-53. PubMed ID: 20619302
[TBL] [Abstract][Full Text] [Related]
22. Modulation of telomere shelterin by TRF1 [corrected] and TRF2 interacts with telomerase to maintain the telomere length in non-small cell lung cancer.
Hsu CP; Ko JL; Shai SE; Lee LW
Lung Cancer; 2007 Dec; 58(3):310-6. PubMed ID: 17681636
[TBL] [Abstract][Full Text] [Related]
23. c-Myc interacts with TRF1/PIN2 and regulates telomere length.
Kim H; Chen J
Biochem Biophys Res Commun; 2007 Nov; 362(4):842-7. PubMed ID: 17765874
[TBL] [Abstract][Full Text] [Related]
24. Expressions of p53, c-MYC, BCL-2 and apoptotic index in human osteosarcoma and their correlations with prognosis of patients.
Wu X; Cai ZD; Lou LM; Zhu YB
Cancer Epidemiol; 2012 Apr; 36(2):212-6. PubMed ID: 21890444
[TBL] [Abstract][Full Text] [Related]
25. Expression of telomere-associated genes as prognostic markers for overall survival in patients with non-small cell lung cancer.
Lin X; Gu J; Lu C; Spitz MR; Wu X
Clin Cancer Res; 2006 Oct; 12(19):5720-5. PubMed ID: 17020976
[TBL] [Abstract][Full Text] [Related]
26. hTERT, the catalytic component of telomerase, is downregulated in the haematopoietic stem cells of patients with chronic myeloid leukaemia.
Campbell LJ; Fidler C; Eagleton H; Peniket A; Kusec R; Gal S; Littlewood TJ; Wainscoat JS; Boultwood J
Leukemia; 2006 Apr; 20(4):671-9. PubMed ID: 16498395
[TBL] [Abstract][Full Text] [Related]
27. Increased expression of telomere length regulating factors TRF1, TRF2 and TIN2 in patients with adult T-cell leukemia.
Bellon M; Datta A; Brown M; Pouliquen JF; Couppie P; Kazanji M; Nicot C
Int J Cancer; 2006 Nov; 119(9):2090-7. PubMed ID: 16786598
[TBL] [Abstract][Full Text] [Related]
28. PD-1 and PD-L1 expression in bone and soft tissue sarcomas.
Torabi A; Amaya CN; Wians FH; Bryan BA
Pathology; 2017 Aug; 49(5):506-513. PubMed ID: 28688724
[TBL] [Abstract][Full Text] [Related]
29. Up-regulation of telomere-binding proteins, TRF1, TRF2, and TIN2 is related to telomere shortening during human multistep hepatocarcinogenesis.
Oh BK; Kim YJ; Park C; Park YN
Am J Pathol; 2005 Jan; 166(1):73-80. PubMed ID: 15632001
[TBL] [Abstract][Full Text] [Related]
30. p53/MDM-2 immunohistochemical expression correlated with proliferative activity in different subtypes of human sarcomas: a ten-year follow-up study.
Stefanou DG; Nonni AV; Agnantis NJ; Athanassiadou SE; Briassoulis E; Pavlidis N
Anticancer Res; 1998; 18(6B):4673-81. PubMed ID: 9891539
[TBL] [Abstract][Full Text] [Related]
31. Telomere length is shorter in affected members of families with familial nonmedullary thyroid cancer.
He M; Bian B; Gesuwan K; Gulati N; Zhang L; Nilubol N; Kebebew E
Thyroid; 2013 Mar; 23(3):301-7. PubMed ID: 23009101
[TBL] [Abstract][Full Text] [Related]
32. Correlations of telomere length, telomerase activity, and telomeric-repeat binding factor 1 expression in colorectal carcinoma.
Garcia-Aranda C; de Juan C; Diaz-Lopez A; Sanchez-Pernaute A; Torres AJ; Diaz-Rubio E; Balibrea JL; Benito M; Iniesta P
Cancer; 2006 Feb; 106(3):541-51. PubMed ID: 16388518
[TBL] [Abstract][Full Text] [Related]
33. No correlation of c-myc overexpression and p53 mutations in liposarcomas.
Schneider-Stock R; Walter H; Rys J; Radig K; Hoang-Vu C; Roessner A
Virchows Arch; 1998 Oct; 433(4):315-21. PubMed ID: 9808433
[TBL] [Abstract][Full Text] [Related]
34. [Localization of human telomere repeat binding factor 1 in telomerase-positive and-negative cells and its expression during cell cycle].
Lan JP; La XY; Zhu YY; Sun J; Li JY; Yu J; Tan YM; Shi JM; Lin MF; Huang H
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2004 Nov; 33(6):475-80, 495. PubMed ID: 15586401
[TBL] [Abstract][Full Text] [Related]
35. Ets2 binding site single nucleotide polymorphism at the hTERT gene promoter--effect on telomerase expression and telomere length maintenance in non-small cell lung cancer.
Hsu CP; Hsu NY; Lee LW; Ko JL
Eur J Cancer; 2006 Jul; 42(10):1466-74. PubMed ID: 16737810
[TBL] [Abstract][Full Text] [Related]
36. A dynamic molecular link between the telomere length regulator TRF1 and the chromosome end protector TRF2.
Houghtaling BR; Cuttonaro L; Chang W; Smith S
Curr Biol; 2004 Sep; 14(18):1621-31. PubMed ID: 15380063
[TBL] [Abstract][Full Text] [Related]
37. Regulation of telomerase by telomeric proteins.
Smogorzewska A; de Lange T
Annu Rev Biochem; 2004; 73():177-208. PubMed ID: 15189140
[TBL] [Abstract][Full Text] [Related]
38. Time-Dependent Effects of POT1 Knockdown on Proliferation, Tumorigenicity, and HDACi Response of SK-OV3 Ovarian Cancer Cells.
Zhou H; Mondal A; Dakic A; Alhawas L; Liu X; He Z
Biomed Res Int; 2018; 2018():7184253. PubMed ID: 29546066
[TBL] [Abstract][Full Text] [Related]
39. Telomere biology: a new player in the end zone.
Colgin L; Reddel R
Curr Biol; 2004 Oct; 14(20):R901-2. PubMed ID: 15498484
[TBL] [Abstract][Full Text] [Related]
40. A robust assay for alternative lengthening of telomeres in tumors shows the significance of alternative lengthening of telomeres in sarcomas and astrocytomas.
Henson JD; Hannay JA; McCarthy SW; Royds JA; Yeager TR; Robinson RA; Wharton SB; Jellinek DA; Arbuckle SM; Yoo J; Robinson BG; Learoyd DL; Stalley PD; Bonar SF; Yu D; Pollock RE; Reddel RR
Clin Cancer Res; 2005 Jan; 11(1):217-25. PubMed ID: 15671549
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
